DOYLE THOMAS JAMES bought KURA
January 2, 2026 · Form 4 insider transaction
DOYLE THOMAS JAMES bought 21,250 shares of Kura Oncology, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
21,250
Price
$0.00
Total value
N/A
InsiderDOYLE THOMAS JAMES
RoleOfficer
CompanyKura Oncology, Inc. (KURA)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 2, 2026
Filing dateJanuary 6, 2026
Shares owned after152,309
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/27, 1/26/28, 1/26/29 and 1/26/30.; Includes 802 shares acquired on November 17, 2025 pursuant to the Issuer's Employee Stock Purchase Plan.